Otezla (apremilast) is a prescription medication used for the treatment of certain inflammatory conditions, including psoriasis and psoriatic arthritis. It belongs to a class of drugs known as phosphodiesterase 4 (PDE4) inhibitors, which work by reducing inflammation in the body. Otezla is administered in tablet form and is taken orally, usually once or twice a day, depending on the specific condition being treated and the patient's response to the medication. It is designed to help manage symptoms such as joint pain, stiffness, and skin plaques associated with psoriasis, improving the quality of life for those affected by these conditions. As with any medication, it is important to use Otezla under the guidance of a healthcare professional, who can provide advice on proper dosage and monitor for potential side effects.